ARIAD Pharmaceuticals Inc.

Cambridge, MA, United States

ARIAD Pharmaceuticals Inc.

Cambridge, MA, United States
SEARCH FILTERS
Time filter
Source Type

Patent
ARIAD Pharmaceuticals Inc. | Date: 2017-04-17

The invention features compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.


Patent
ARIAD Pharmaceuticals Inc. | Date: 2015-05-13

Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.


Patent
ARIAD Pharmaceuticals Inc. | Date: 2017-08-30

The invention features compounds of the general formula (VIa) in which the variable groups are as defined herein, and to their preparation and use.


Patent
ARIAD Pharmaceuticals Inc. | Date: 2017-03-22

Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFRand mutant HER2 activity, are described herein.


Patent
ARIAD Pharmaceuticals Inc. | Date: 2017-04-26

Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFRand mutant HER2 activity, are described herein.


Patent
ARIAD Pharmaceuticals Inc. | Date: 2015-05-13

Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.


Patent
ARIAD Pharmaceuticals Inc. | Date: 2016-01-25

The invention features compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.


Patent
ARIAD Pharmaceuticals Inc. | Date: 2015-01-28

The invention features methods and compositions for the synthesis of multimerizing agents.


Patent
ARIAD Pharmaceuticals Inc. | Date: 2016-01-21

This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.


Patent
ARIAD Pharmaceuticals Inc. | Date: 2016-02-16

The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of Formula I: wherein the variables are as defined herein.

Loading ARIAD Pharmaceuticals Inc. collaborators
Loading ARIAD Pharmaceuticals Inc. collaborators